Legend Biotech (LEGN) FCF Payout Ratio Growth (1y) (2020 - 2025)
Legend Biotech (LEGN) FCF Payout Ratio Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 68.88% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -31.89% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 110.75% |
| Jun 30, 2025 | -1,731.32% |
| Mar 31, 2025 | -110.14% |
| Sep 30, 2024 | -176.91% |
| Jun 30, 2024 | 6,257.31% |
| Mar 31, 2024 | 943.25% |
| Sep 30, 2023 | 170.71% |
| Jun 30, 2023 | -3,399.89% |
| Mar 31, 2023 | -2.21% |
| Sep 30, 2022 | -292.59% |
| Jun 30, 2022 | 113.87% |
| Mar 31, 2022 | 68.92% |
| Dec 31, 2021 | -90.35% |
| Sep 30, 2021 | 84.17% |
| Jun 30, 2021 | 81.65% |
| Mar 31, 2021 | -317.74% |
| Dec 31, 2020 | -66.66% |
| Jun 30, 2020 | -611.05% |